New Shares Bring $15.8 Million
- Share via
IRVINE — CoCensys Inc. grossed about $15.8 million in an offering of 2.43 million common shares at $6.50 a share, mainly to institutional investors.
The biopharmaceutical company, which develops and markets products to treat neurological and psychiatric disorders, said the proceeds, along with existing funds, will be used for research and development of the company’s products and for general corporate purposes.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
